Detalhe da pesquisa
1.
Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Protects Striatal Cells and Improves Motor Function in Huntington's Disease Models: Role of PAC1 Receptor.
Front Pharmacol
; 12: 797541, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35153755
2.
Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Against Cognitive Decline in Neurodegenerative Diseases.
Front Cell Neurosci
; 14: 221, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32765225
3.
Decreased Myocyte Enhancer Factor 2 Levels in the Hippocampus of Huntington's Disease Mice Are Related to Cognitive Dysfunction.
Mol Neurobiol
; 57(11): 4549-4562, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32757160